Guideline Concordance for HFrEF Therapy in the United Arab Emirates: Retrospective Real-World Data Benchmarked Against Canadian Practice
International Journal of Clinical Pharmacy and Medicine · 10.07.2026 · 1 (2)
DOI: 10.68760/ijcpm.2026.05 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Clinical Pharmacy and Medicine, online erschienen am 10.07.2026. Verfasst von Mohamed Abdellatif.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdellatif, M. (2026). Guideline Concordance for HFrEF Therapy in the United Arab Emirates: Retrospective Real-World Data Benchmarked Against Canadian Practice. International Journal of Clinical Pharmacy and Medicine, 1(2). https://doi.org/10.68760/ijcpm.2026.05
Vancouver
Abdellatif M. Guideline Concordance for HFrEF Therapy in the United Arab Emirates: Retrospective Real-World Data Benchmarked Against Canadian Practice. International Journal of Clinical Pharmacy and Medicine. 2026;1(2). doi:10.68760/ijcpm.2026.05
BibTeX
@article{Abdellatif2026,
author = {Abdellatif, Mohamed},
title = {Guideline Concordance for HFrEF Therapy in the United Arab Emirates: Retrospective Real-World Data Benchmarked Against Canadian Practice},
journal = {International Journal of Clinical Pharmacy and Medicine},
year = {2026},
volume = {1},
number = {2},
doi = {10.68760/ijcpm.2026.05}
}
EUVIMED